Artal Group S.A. Selecta Biosciences Inc Transaction History

Artal Group S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.4 $4.42 Million - $5.95 Million	4,253,435 Added 87.1%	9,136,635 $10.2 Million
Q2 2022 Aug 11, 2022	BUY	$0.67 - $1.4 $591,744 - $1.24 Million	883,200 Added 22.08%	4,883,200 $6.4 Million
Q2 2021 Aug 13, 2021	SELL	$2.82 - $5.01 $1.41 Million - $2.51 Million	-500,000 Reduced 11.11%	4,000,000 $16.7 Million
Q3 2020 Nov 13, 2020	BUY	$2.18 - $2.84 $3.49 Million - $4.54 Million	1,600,000 Added 55.17%	4,500,000 $11.2 Million
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $939,941 - $2.09 Million	-513,629 Reduced 15.05%	2,900,000 $8.24 Million
Q4 2019 Feb 13, 2020	BUY	$1.32 - $2.47 $1.73 Million - $3.24 Million	1,313,629 Added 62.55%	3,413,629 $8.12 Million
Q1 2019 May 10, 2019	BUY	$1.47 - $3.06 $2.21 Million - $4.59 Million	1,500,000 Added 250.0%	2,100,000 $4.98 Million
Q4 2018 Feb 11, 2019	BUY	$2.66 - $15.93 $102,303 - $612,667	38,460 Added 6.85%	600,000 $1.6 Million
Q3 2018 Nov 09, 2018	BUY	$12.07 - $16.0 $742,787 - $984,640	61,540 Added 12.31%	561,540 $8.73 Million
Q2 2018 Aug 10, 2018	BUY	$9.36 - $13.25 $3.51 Million - $4.97 Million	375,000 Added 300.0%	500,000 $6.63 Million
Q1 2018 May 10, 2018	BUY	$8.49 - $11.82 $1.06 Million - $1.48 Million	125,000 New	125,000 $1.27 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.